Nonalcoholic fatty liver disease (NAFLD) is a common liver disease, with a worldwide
prevalence of 25%. NAFLD is a spectrum that includes nonalcoholic fatty liver defined …

High prevalence of non-alcoholic fatty liver disease (NAFLD) and very diverse outcomes that
are related to disease form and severity at presentation have made the search for …

The aim of this study was to validate the diagnostic efficacy of acoustic attenuation imaging
(ATI) and ultrasonic shear wave elastography (SWE) in classifying nonalcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) is based on the concept of pathological
morphology as well as clinical findings, and is broadly categorized into nonalcoholic fatty …

Purpose Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder that frequently
coexists with obesity, metabolic syndrome, and type 2 diabetes. The NAFLD spectrum …

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem afflicting
approximately one billion individuals worldwide. Liver biopsy is considered the gold …

The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) has increased rapidly worldwide, making NAFLD/NASH an important global health …

Background Hepatic steatosis is a condition frequently encountered in clinical practice, with
potential progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. Detection …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease. The progressive subtype of NAFLD or nonalcoholic steatohepatitits (NASH), may …

Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a
worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and …